[HTML][HTML] Nanovaccines: a game changing approach in the fight against infectious diseases

MAH Abusalah, H Chopra, A Sharma… - Biomedicine & …, 2023 - Elsevier
The field of nanotechnology has revolutionised global attempts to prevent, treat, and
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …

Immunomodulatory approaches in managing lung inflammation in COVID‐19: a double‐edge sword

G Verma, M Dhawan, ARA Saied… - Immunity …, 2023 - Wiley Online Library
Introduction The novel coronavirus infectious disease 2019 (COVID‐19) which is caused by
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged as a gigantic …

[HTML][HTML] An updated review on pathogenic coronaviruses (CoVs) amid the emergence of SARS-CoV-2 variants: A look into the repercussions and possible solutions

AA Rabaan, MF Alenazy, AA Alshehri… - Journal of Infection and …, 2023 - Elsevier
Abstract SARS-CoV-2, responsible for COVID-19, shares 79% and 50% of its identity with
SARS-CoV-1 and MERS-CoV, respectively. It uses the same main cell attachment and entry …

Interface design of SARS-CoV-2 symmetrical nsp7 dimer and machine learning-guided nsp7 sequence prediction reveals physicochemical properties and hotspots for …

AJ Yadav, S Kumar, S Maurya, K Bhagat… - Physical Chemistry …, 2024 - pubs.rsc.org
The COVID-19 pandemic, driven by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), necessitates a profound understanding of the virus and its lifecycle. As an …

Evolution and implications of SARS-CoV-2 variants in the post-pandemic era

E Manirambona, OJ Okesanya, NO Olaleke… - Discover Public …, 2024 - Springer
Abstract SARS-CoV-2, the cause of the COVID-19 pandemic, has introduced a challenging
era characterized by the persistent emergence of subvariants. Even after the World Health …

Current Advances in Viral Nanoparticles for Biomedicine

X Sun, T Tian, Y Lian, Z Cui - ACS nano, 2024 - ACS Publications
Viral nanoparticles (VNPs) have emerged as crucial tools in the field of biomedicine.
Leveraging their biological and physicochemical properties, VNPs exhibit significant …

Using a static magnetic field to attenuate the severity in COVID-19-invaded lungs

HY Lai, KC Fan, YH Lee, WZ Lew, WY Lai, SY Lee… - Scientific Reports, 2024 - nature.com
Two important factors affecting the progress of coronavirus disease 2019 (COVID-19)
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are the S …

COVID-19: A threat to the respiratory system

G Rasool, WA Khan, AM Khan, M Riaz… - International …, 2024 - journals.sagepub.com
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causes acute
coronavirus disease-19 (COVID-19) that has emerged on a pandemic level. Coronaviruses …

Therapeutic Potential of Neutralizing Monoclonal Antibodies (nMAbs) against SARS-CoV-2 Omicron Variant

P Parua, S Ghosh, K Jana, A Seth… - Current …, 2024 - benthamdirect.com
Background The COVID-19 pandemic has spurred significant endeavors to devise
treatments to combat SARS-CoV-2. A limited array of small-molecule antiviral drugs …

Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2—Review of the Evidence

I Bolesławska, M Kowalówka, N Bolesławska-Król… - Viruses, 2023 - mdpi.com
One of the proposed nutritional therapies to support drug therapy in COVID-19 is the use of
a ketogenic diet (KD) or ketone bodies. In this review, we summarized the evidence from …